DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 71 filers reported holding DURATA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $227,000 | – | 17,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VII LLC | 1,902,030 | $25,620,000 | 32.83% |
| Aisling Capital LLC | 3,030,175 | $40,800,000 | 28.35% |
| SOPHROSYNE CAPITAL LLC | 105,500 | $1,422,000 | 1.24% |
| EAM Investors, LLC | 197,888 | $2,664,000 | 0.48% |
| Orbimed Advisors | 1,785,714 | $24,046,000 | 0.30% |
| Granahan Investment Management | 529,733 | $7,133,000 | 0.19% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 939,182 | $12,647,000 | 0.09% |
| Lenox Wealth Advisors, LLC | 8,000 | $114,000 | 0.07% |
| SSI INVESTMENT MANAGEMENT LLC | 33,985 | $459,000 | 0.05% |
| KANAWHA CAPITAL MANAGEMENT LLC | 13,000 | $175,000 | 0.03% |